Timing for Cervical Checks During Prenatal Ambulatory Care
Cervical cytology (Pap smear) should begin approximately 3 years after initiation of sexual intercourse but no later than age 21, and can be performed during pregnancy if due; transvaginal cervical length ultrasound should be assessed at the 18-22 week anatomy scan in all singleton pregnancies to screen for short cervix and prevent preterm birth.
Cervical Cytology (Pap Smear) Timing
When to Start and Frequency
- Initiation: Begin screening approximately 3 years after first sexual intercourse, but no later than age 21 1
- Frequency for women <30 years: Annual screening 1
- Frequency for women ≥30 years: Every 2-3 years after three consecutive negative results 1
During Pregnancy
Cervical cytology is safe during pregnancy and should be performed if screening is due based on the patient's routine screening schedule 2. The procedure does not harm the mother or fetus when performed correctly. However, interpretation requires careful consideration due to physiological cervical changes during pregnancy that may mimic pathological findings 2.
When to Stop
- Discontinue after total hysterectomy for benign indications with no history of high-grade CIN 1
- Continue screening after hysterectomy if history of CIN 2 or 3 until three consecutive negative results 1
Transvaginal Cervical Length Ultrasound Timing
Universal Screening Recommendation
Assessment of the cervix should be attempted at the 18-22 week anatomy ultrasound in all singleton pregnancies 3. This timing represents the optimal window for detecting short cervix and implementing interventions that reduce preterm birth and improve perinatal outcomes.
Technique and Approach
- Initial assessment: Begin with transabdominal visualization during the anatomy scan 3
- Transvaginal ultrasound indicated when:
For High-Risk Patients (Prior Spontaneous Preterm Birth)
Serial cervical length measurements every 2 weeks between 16-23 6/7 weeks are recommended 4, 5. If cervical length is 25-29 mm, increase frequency to weekly 4.
Critical Thresholds and Actions
For patients WITHOUT prior preterm birth:
- Cervical length ≤20 mm before 24 weeks: Prescribe vaginal progesterone (200 mg suppository or 90 mg gel daily until 36 weeks) - this reduces preterm birth by approximately 45% 3, 4
- Cervical length 21-25 mm: Consider vaginal progesterone based on shared decision-making 3
For patients WITH prior spontaneous preterm birth:
- Cervical length ≤25 mm before 24 weeks: Offer cerclage (reduces preterm birth <35 weeks by 30% and composite perinatal mortality/morbidity by 36%) 4, 5
- Vaginal progesterone also recommended 5
Important Technical Considerations
Perform the transvaginal ultrasound soon after bladder voiding or wait until the end of the anatomy scan (ideally within 30 minutes after voiding) to minimize lower uterine segment contractions, which occur in 16-43% of cases and can falsely shorten cervical length measurements 6. If contractions persist after waiting 20 minutes, report only the true cervical length and consider repeating in ≤7 days for high-risk patients 6.
What NOT to Do
- Do not use 17-alpha hydroxyprogesterone caproate for short cervix treatment 3
- Do not place cerclage in patients without prior preterm birth who have short cervix (10-25 mm) without cervical dilation 3
- Do not use cervical pessary for singleton gestations with short cervix 3
- Do not routinely screen twin gestations with cervical length, as no effective interventions are proven outside clinical trials 3
Health Equity Consideration
This screening is particularly important given that Non-Hispanic Black pregnant individuals have a preterm birth rate of 14.4% compared to 9.0-10.0% in other racial/ethnic groups, disparities that persist even after controlling for socioeconomic factors 3. Universal cervical length screening at 18-22 weeks provides an evidence-based opportunity to identify and treat at-risk patients regardless of prior history, potentially reducing these disparities.